The antibody contract manufacturing market is estimated to be worth USD 17 billion - Roots Analysis'
The benefits of engaging a CMO orCDMO for antibody development and production extend beyond fulfilling the needsof small companies; access to new technologies and operational flexibility are attractiveattributes to larger players as well
Roots Analysis is pleased toannounce the publication of its recent study, titled, “Antibody Contract Manufacturing Market, 2020-2030” reportto its list of offerings.
The report features an extensive study of thecurrent market landscape and future opportunities associated with the contractmanufacturing of antibodies. The study also features a detailed analysis of keydrivers and trends related to this evolving domain. In addition to otherelements, the study includes:
§ Adetailed review of the overall landscape of companies, offering contractservices for the manufacturing of antibodies.
§ Acompetitiveness analysis of key players engaged in this domain, featuring anassessment based on their supplier strength and service strength.
§ Abenchmark analysis, highlighting the key focus areas of small, mid-sized andlarge companies, comparing their existing capabilities within and beyond theirrespective (geography-based) peer groups.
§ Ananalysis of the various partnerships pertaining to contract manufacturing ofantibodies, which have been established since 2013.
§ Ananalysis of the various expansion initiatives undertaken by service providers,in order to augment their respective antibody manufacturing capabilities, overthe period 2017-2019 (till October).
§ Anestimate of the overall, installed capacity for manufacturing antibodies basedon data reported by industry stakeholders in the public domain.
§ Informedestimates of the annual commercial and clinical demand for antibodies, based onvarious relevant parameters, such as target patient population, dosingfrequency and dose strength.
§ Elaborateprofiles of the key industry players that offer contract manufacturing servicesat all scales of operation and have more than two manufacturing facilities.
§ Acase study comparing the key characteristics of large molecule and smallmolecule drugs, along with details on the various steps and challenges involvedin their respective manufacturing processes.
§ Adiscussion on affiliated trends, key drivers and challenges, under a SWOTframework, which are likely to impact the industry’s evolution.
§ Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
§ Type of Antibodies
§ Monoclonal Antibodies
§ Bispecific Antibodies
§ ADCs
§ Others
§ Company Size
§ Small
§ Mid-sized
§ Large / Very Large
§ Scale of Operation
§ Preclinical / Clinical
§ Commercial
§ Type of expressionsystem used
§ Mammalian
§ Microbial
§ Key geographicalregions
§ North America
§ Europe
§ Asia and RoW
§ Transcripts ofinterviews held with the following senior level representatives of stakeholdercompanies:
§ Dietmar Katinger (ChiefExecutive Officer, Polymun Scientific)
§ David C Cunningham (Director,Corporate Development, Goodwin Biotechnology)
§ Claire Otjes (MarketingManager, Batavia Biosciences)
Keycompanies covered in the report
§ AGC Biologics
§ Aldevron
§ AMRI
§ Boehringer IngelheimBioXcellence
§ Emergent BioSolutions
§ Eurofins CDMO
§ FUJIFILM DiosynthBiotechnologies
§ KBI Biopharma
§ Lonza
§ Nitto Avecia PharmaServices
§ Novasep
§ Pierre Fabre
§ Samsung BioLogics
§ Synthon
§ Thermo FisherScientific
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
OtherRecent Offerings
1. Bispecific AntibodyTherapeutics Market (4th Edition), 2019-2030
2. Antibody DrugConjugates (ADCs) - Linker and Conjugation Technologies Market,2019-2030
3. Antibody DrugConjugates Market (5th Edition), 2019-2030
AboutRoots Analysis
RootsAnalysis is one of the fastest growing market research companies, sharing freshand independent perspectives in the bio-pharmaceutical industry. The in-depthresearch, analysis and insights are driven by an experienced leadership teamwhich has gained many years of significant experience in this sector. If you’dlike help with your growing business needs, get in touch atinfo@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
gaurav.chaudhary@rootsanalysis.com
